Clinical Trial Update: Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial [NA]

View source ↗

Summary

A single-center randomized trial compares two prolonged-release tacrolimus variants (Advagraf vs Envarsus) to evaluate safety and efficacy after liver transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Rejection

Drugs mentioned

• Advagraf (tacrolimus)
• Envarsus (tacrolimus)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Liver Transplant Rejection, Immunosuppression | NA | Status: UNKNOWN